CCG Wealth Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,000	Closed	-$19.7K	–	67
2023 Q1	$19.7K	Hold	5,000	–	–	0.01%	62
2022 Q4	$15K	Buy	5,000 +1,667	+50%	+$5K	0.01%	100
2022 Q3	$18K	Buy	+3,333	New	+$18K	0.01%	94